Plasma homocysteine and the severity of heart failure in patients with previous myocardial infarction.
Journal Title: Cardiology Journal - Year 2011, Vol 18, Issue 1
Abstract
Homocysteine is considered to be a risk factor, or an indicator of risk, for the development of cardiovascular disease. Little data is available on its significance in patients with previous myocardial infarction. The aim of our study was to assess the plasma level of homocysteine and its relationship with the severity of heart failure in patients with chronic myocardial infarction.
Authors and Affiliations
Lucia Agoston-Coldea, Teodora Mocan, Marc Gatfosse, Silvia Lupu, Dan L Dumitrascu
Keywords
Related Articles
- EP ID EP85629
- DOI -
- Views 86
- Downloads 0
Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
Dual antiplatelet therapy is currently recommended for all patients with acute coronary syndromes, independent of whether they receive pharmacological treatment or undergo percutaneous coronary intervention. Antiplatelet...
Karel Frederick Wenckebach (1864-1940): A giant of medicine.
Treating depression: psychiatric consultation in cardiology.
Depression is the most common psychiatric disorder in coronary artery disease, and it can worsen cardiac outcomes. Also, cardiac disease predisposes patients to the development of depression. Assessment of depression is...
Left atrial myxoma with an atrial septal defect.
In a 62-year old woman with arterial hypertension, a left atrial myxoma and a concomitant atrial septal defect, diagnosed intraoperatively, were recognized. The atrial septal defect was not observed pre-operatively by tr...
Access strategies for peripheral arterial intervention.
An operator's ability to determine the optimal vascular access strategy for patients undergoing peripheral endovascular intervention is critical to maximizing procedural safety and success. Individualizing an approach to...